The relationship between circulating irisin levels and endothelial function in lean and obese subjects

Clinical Endocrinology

Volumn 83, Issue 3, 2015, Pages 339-343

  Hou, Ningning ^a   Han, Fang ^a   Sun, Xiaodong ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FATTY ACID; INSULIN; IRISIN; MALONALDEHYDE; TRIACYLGLYCEROL; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD BIOCHEMISTRY; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; MALE; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION; WAIST CIRCUMFERENCE; BLOOD; METABOLISM; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; REGRESSION ANALYSIS; VASCULAR ENDOTHELIUM; YOUNG ADULT;

ADIPONECTIN; ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; ENDOTHELIUM, VASCULAR; FATTY ACIDS, NONESTERIFIED; FEMALE; FIBRONECTINS; HUMANS; INSULIN; MALE; MALONDIALDEHYDE; MULTIVARIATE ANALYSIS; OBESITY; REGRESSION ANALYSIS; TRIGLYCERIDES; VASODILATION; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84940101446     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12658     Document Type: Article

References (24)

1. Bostrom, P., Wu, J., Jedrychowski, M.P., et al,. (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481, 463-468.
2. Elbelt, U., Hofmann, T., &, Stengel, A., (2013) Irisin: what promise does it hold. Current opinion in clinical nutrition and metabolic care, 16, 541-547.
3. Choi, Y.K., Kim, M.K., Bae, K.H., et al,. (2013) Serum irisin levels in new-onset type 2 diabetes. Diabetes research and clinical practice, 100, 96-101.
4. Liu, J.J., Wong, M.D., Toy, W.C., et al,. (2013) Lower circulating irisin is associated with type 2 diabetes mellitus. Journal of diabetes and its complications, 27, 365-369.
5. Polyzos, S.A., Kountouras, J., Anastasilakis, A.D., et al,. (2014) Irisin in patients with nonalcoholic fatty liver disease. Metabolism: Clinical and Experimental, 63, 207-217.
6. Zhang, H.J., Zhang, X.F., Ma, Z.M., et al,. (2013) Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. Journal of hepatology, 59, 557-562.
7. Villarroya, F., (2012) Irisin, turning up the heat. Cell metabolism, 15, 277278.
8. Bonetti, P.O., Lerman, L.O., &, Lerman, A., (2003) Endothelial dysfunction: a marker of atherosclerotic risk. Arteriosclerosis, thrombosis, and vascular biology, 23, 168-175.
9. Hou, N., Han, F., &, Wang, M., et al,. (2014) Perirenal fat associated with microalbuminuria in obese rats. International urology and nephrology, 46, 839-845.
10. Sun, X., Yu, Y., &, Han, L., (2013) High FFA levels related to microalbuminuria and uncoupling of VEGF-NO axis in obese rats. International urology and nephrology, 45, 1197-1207.
11. Li, H., Li, H., Bao, Y., et al,. (2011) Free fatty acids induce endothelial dysfunction and activate protein kinase C and nuclear factor-kappaB pathway in rat aorta. International journal of cardiology, 152, 218-224.
12. Organization WH International association for the study of obesity/International obesity task force (2000) The Asia-Pacific Perspective: redefining obesity and its treatment. Health Communications, Sydney.
13. Pan, X.R., Yang, W.Y., Li, G.W., et al,. (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care, 20, 1664-1669.
14. Kirma, C., Akcakoyun, M., Esen, A.M., et al,. (2007) Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circulation Journal: Official Journal of the Japanese Circulation Society, 71, 698-702.
15. Magen, E., Viskoper, J.R., Mishal, J., et al,. (2005) Effects of low-dose aspirin on blood pressure and endothelial function of treated hypertensive hypercholesterolaemic subjects. Journal of human hypertension, 19, 667-673.
16. Roberts, M.D., Bayless, D.S., Company, J.M., et al,. (2013) Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats. Metabolism: Clinical and Experimental, 62, 1052-1056.
17. Moreno-Navarrete, J.M., Ortega, F., Serrano, M., et al,. (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 98, E769-E778.
18. Yu, Y.R., Li, H.L., Yu, H.L., et al,. (2003) The relationship between insulin resistance and endothelium-dependent vasodilatation in obese subjects. Zhonghua yi xue za zhi, 83, 1467-1470.
19. Chinen, I., Shimabukuro, M., Yamakawa, K., et al,. (2007) Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology, 148, 160-165.
20. Deng, G., Long, Y., Yu, Y.R., et al,. (2010) Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS Pathway. International Journal of Obesity (2005), 34, 165-171.
21. Castillo-Quan, J.I., (2012) From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity. Disease Models & Mechanisms, 5, 293295.
22. Choi, K.C., Ryu, O.H., Lee, K.W., et al,. (2005) Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats. Biochemical and biophysical research communications, 336, 747-753.
23. Tsuchida, A., Yamauchi, T., Takekawa, S., et al,. (2005) Peroxisome proliferator-activated receptor (PPAR)alpha activation increases adiponectin receptors and reduces obesity-related inflammation in adipose tissue: comparison of activation of PPARalpha, PPARgamma, and their combination. Diabetes, 54, 3358-3370.
24. Li, H., Xiao, Y., Liu, H., et al,. (2011) Hypoadiponectinemia predicts impaired endothelium-independent vasodilation in newly diagnosed type 2 diabetic patients: an 8-year prospective study. Chinese Medical Journal, 124, 3607-3612.